Announcements

/Announcements

April 2017

Interpace Diagnostics to Present at RedChip’s Global Online Growth Conference

PARSIPPANY, N.J., April 24, 2017 /PRNewswire/ -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) [...]

Interpace Diagnostics Eliminates Long Term Secured Debt

PARSIPPANY, N.J., April 20, 2017 /PRNewswire/ -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) [...]

Interpace Announces Coverage of ThyraMIR® with UnitedHealthcare

PARSIPPANY, N.J., April 18, 2017 /PRNewswire/ -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) [...]

Interpace Diagnostics Announces Receipt of Letter From Nasdaq Confirming Compliance With Minimum Stockholders’ Equity Requirement

PARSIPPANY, N.J., April 13, 2017 /PRNewswire/ -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) [...]

Interpace Diagnostics Announces European Patent Approval For Underlying Technology of its ThyraMIR® microRNA Classifier

PARSIPPANY, N.J., April 3, 2017 /PRNewswire/ -- Interpace Diagnostics Group, Inc. (IDXG) ("Interpace" [...]

March 2017

Interpace Diagnostics Group Reports Fourth Quarter and Full Year 2016 Financial Results, Business Progress Against Plan and Recent Accomplishments

PARSIPPANY, N.J., March 29, 2017 /PRNewswire/ -- Interpace Diagnostics Group, Inc. (IDXG) ("Interpace" [...]

Interpace Diagnostics Group Announces Timing of Earnings Release and Investor Conference Call

PARSIPPANY, N.J., March 28, 2017 /PRNewswire/ -- Interpace Diagnostics Group, Inc. (IDXG) (the [...]

Interpace Diagnostics Group Announces Agreements to Successfully Restructure Debt and Terminate Royalty and Milestone Obligations

PARSIPPANY, N.J., March 23, 2017 /PRNewswire/ -- Interpace Diagnostics Group, Inc. (IDXG) (the [...]

Interpace Diagnostics Participates in USA Today Endocrine Health Campaign – Company Joins Key Partners in National Educational Effort

PARSIPPANY, N.J., March 20, 2017 /PRNewswire/ -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG), [...]

February 2017

Interpace Diagnostics to Present New Data on Thyroid Product Performance

PARSIPPANY, N.J., Feb. 27, 2017 /PRNewswire/ -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG), [...]